Follow Us 
Good news for Kohli's RCB before IPL 2026 season, hit JACKPOT as THIS person with net worth of Rs 1360000000000 shows interest in...
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Serum Institute Of India
Serum Institute Of India News
Meet richest man in Pune, who has a net worth of over Rs 204300 crore, owns Rs 750 crore home, his business is..., he is India's...
Sumaila Zaman October 25, 2024 8:27 AM IST
According to the 2024 Hurun India Rich List, Cyrus S. Poonawalla & Family, the chairman and managing director of the Cyrus Poonawalla Group, has a wealth of Rs 2,89,900 crore.
Sharad Pawar Demands Bharat Ratna For SII Founder Cyrus Poonawalla
Ishaan Srivastava February 14, 2024 10:04 PM IST
Nationalist Congress Party founder Sharad Pawar has called for Cyrus Poonawalla, founder of Serum Institute Of India (SII), to be awarded with the 'Bharat Ratna' for his outstanding contributions to vaccine production in India.
Serum Institute of India Duped of Rs 1 Crore as Fraudsters Ask For Money Transfer in CEO Adar Poonawalla's Name
India.com News Desk September 10, 2022 7:00 PM IST
Satish Deshpande, one of the directors of SII Pune, received WhatsApp messages from a person posing as Adar Poonawalla, according to the FIR.
Cervical Cancer: All About India's First Homegrown Vaccine, Its Price, Launch Date, And How Will it Help Prevent Fatal Disease
India.com Lifestyle Staff September 1, 2022 1:55 PM IST
India will launch its first ever self-developed vaccine for the prevention against cervical cancer. The vaccine will be launched in IIC Delhi.
In A First, India To Get Its Vaccine Against Cervical Cancer Tomorrow: Report
India.com News Desk August 31, 2022 3:54 PM IST
Giving details, Dr NK Arora, Chairperson of the COVID working group, National Technical Advisory Group on Immunisation (NTAGI) said it is an exciting experience to launch a made-in-India vaccine.
Covovax, Serum Institute of India's COVID Vaccine, Approved For 12-17 Age Group
India.com News Desk April 29, 2022 5:32 PM IST
The Central Drugs Standard Control Organisation's Subject Expert Committee had approved the Serum Institute of India's Covovax for restricted use in emergency situations in adults on December 28. On March 9, it recommended granting the Emergency Use Authorisation for Covovax for the 12-17 age group.
Urgency Lost: Adar Poonawalla Warns Against Business-as-Usual Approach, Says 'Pandemic Not Behind Us Yet'
India.com News Desk April 22, 2022 5:43 PM IST
Calling for increased adoption of booster doses, Poonawalla said it is also needed because people need to travel internally and outside, and many countries have made booster doses mandatory for travel.
Covishield Vaccine Price Revised For Private Hospitals, Check Latest Rate Here
India.com News Desk April 9, 2022 3:38 PM IST
On Friday, the company had said that the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600 per shot for eligible individuals.
Covishield Booster to Cost Rs 600 With Taxes, Says Poonawala As Govt Allows Precaution Doses For Adults
India.com News Desk April 8, 2022 5:51 PM IST
Giving details, Adar Poonawala said the Serum Institute will offer large discounts to hospitals and distributors who like to offer booster doses.
Booster Shots Mandatory For Travellers: SII's Poonawalla Explains India's Plan to Tackle New COVID Recombinant Variant
India.com News Desk April 5, 2022 2:15 PM IST
Adar Poonawalla asserted that SII has enough stock for the rollout of booster doses. Referring to the other countries that are administering booster doses, Poonawala further said that it's time for India also to look at it.
Net Worth $26 Billion, Vaccine King Cyrus Poonawalla Is World's Richest Healthcare Billionaire
India.com Business Desk March 16, 2022 6:26 PM IST
Cyrus Poonawalla Net Worth: The 'Vaccine King' registered a growth of 41 per cent in this net worth in 2021 and is the fourth richest individual in India. Cyrus Poonawalla's net worth, at present, is $26 billion.
Govt Panel Recommends EUA For Serum Institute's COVID Vaccine - Covovax - For 12-17 Age Group
India.com News Desk March 4, 2022 10:10 PM IST
The Drugs Controller General of India (DCGI) had approved Covovax for restricted emergency use in adults on December 28.
Serum Institute Seeks Emergency Use Approval For Covovax COVID-19 Vaccine For 12-17 Age Group
India.com News Desk February 21, 2022 7:29 PM IST
Covovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing authorisation. It has been granted emergency use listing by the World Health Organisation on December 17, 2021.
Serum Institute of India CEO Adar Poonawalla Advises Novak Djokovic to Get Vaccinated
India.com Sports Desk February 17, 2022 8:08 PM IST
The 34-year-old tennis superstar was detained and eventually deported from Australia for failing to meet that country's strict vaccination requirements.
Maharashtra Man Claims Daughter Died of COVID Vaccine Side Effects, Seeks Rs 1000 Core Compensation
PTI February 1, 2022 10:25 PM IST
Lunawat's plea claimed the Union government's AEFI committee on October 2, 2021 admitted the death of his daughter was due to side effects of Covishield vaccine.
Will Continue to Work For Health Sector: Poonawalla After Being Awarded Padma Bhushan
India.com News Desk January 25, 2022 11:55 PM IST
Apart from Cyrus Poonawalla, other recipients of the prestigious award include Krishna Ella and Suchitra Ella of Bharat Biotech. The awards were announced on the eve of Republic Day.
Bharat Biotech, Serum Institute Seek Full Market Approval For Covaxin, Covishield: DGCI To Review Proposals Today
India.com News Desk January 14, 2022 7:16 AM IST
The Drugs Controller General of India (DCGI) on Friday will review applications filed by Bharat Biotech and Serum Institute of India for full market approval of its respective COVID vaccines - Covaxin and Covishield, sources said.
COVAXIN Now Universal Vaccine For All, Product Development For Licensure Completed: Bharat Biotech
India.com News Desk January 13, 2022 10:12 PM IST
Issuing a statement, Bharat Biotech said the goals of developing a global vaccine against COVID-19 have been achieved.
Govt Panel Rejects Serum Institute s Plea For Covishield as Booster Dose, Seeks More Data: Report
India.com News Desk December 10, 2021 11:41 PM IST
The Serum Institute had earlier sought the approval of the SEC to administer the third dose of its vaccine, citing adequate stock of the jab and increasing demand for booster shots due to Omicron variant threat.
How Effective Is COVISHIELD Against Omicron? Serum Institute's Adar Poonawalla Explains
India.com News Desk November 30, 2021 7:39 PM IST
Giving further details, Poonawala said the focus of the Central government should be on giving both doses of corona vaccine to everyone.
SII Urges Govt to Fast-Track Movement of Increasing Covishield Stock
PTI November 21, 2021 6:17 PM IST
The Serum Institute will commence its Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishiled on November 24.
New Zealand Recognises Covishield, Covaxin; India Waits For Announcement on Lifting of Travel Curbs
India.com News Desk November 17, 2021 5:33 PM IST
It must be noted that Covishield and Covaxin, which received emergency use listing (EUL) from the World Health Organisation, have so far been recognised by 96 countries.
Serum Institute Seeks Approval From DCGI to Manufacture Covovax
India.com News Desk October 29, 2021 9:26 PM IST
The SII has also submitted interim phase 2/3 clinical study report on Indian adults, the interim report of Novavax UK and USA-Mexico phase-3 clinical study and response to the queries raised by the DCGI office, along with its application.
'Faced Harassment 50 Years Ago, But Now...': Here's What Serum Institute Chairman Cyrus Poonawalla Said For PM Modi
India.com News Desk August 14, 2021 12:17 AM IST
Speedy permissions granted by the government authorities made the development of the coronavirus vaccine within a very short time possible, Poonawalla noted.
Subscribe Now
Enroll for our free updates